Mary leads our TPIreg consulting team specializing in US and Canadian Regulatory Affairs. She builds compelling regulatory strategy and leverages her excellent relationship with Health Canada to help prepare clients for Agency interface and negotiations. Mary brings with her broad experience covering 20 years in regulatory consulting, including prescription and OTC drugs (pharmaceuticals, biologics, natural health products), medical devices and cosmetics. Mary has extensive knowledge Canadian regulatory landscape.
Update on InnomarClinics
InnomarClinics remain open to our patients amidst coronavirus (COVID-19) concerns.
Regulatory and Scientific Affairs
Mary Speagle is a contributing author to RAPS Fundamentals of Canadian Regulatory Affairs and served on the Canadian Association of Pharmaceutical Regulatory Affairs (CAPRA) Board of Directors from 2009-2015 in various roles. Mary is a current member CAPRA programming committee and RAPS Editorial Board.